ABVC
ABVC Biopharma IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$35.64M
P/E Ratio
—
EPS
$-0.39
Beta
0.38
52W High
$5.48
52W Low
$0.81
50-Day MA
$1.49
200-Day MA
$2.45
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About ABVC Biopharma Inc
American BriVision (Holding) Corporation, a clinical-stage biopharmaceutical company, develops drugs and medical devices to meet unmet medical needs in the United States.
Fundamentals
| Revenue (TTM) | 797,920 |
| Gross Profit (TTM) | 797,920 |
| EBITDA | $-7.13M |
| Operating Margin | 375.80% |
| Return on Equity | -119.50% |
| Return on Assets | -31.20% |
| Revenue/Share (TTM) | $0.05 |
| Book Value | $0.46 |
| Price-to-Book | 2.54 |
| Price-to-Sales (TTM) | 27.42 |
| EV/Revenue | 40.1 |
| EV/EBITDA | -1.90 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 104.50% |
| Shares Outstanding | $25.64M |
| Float | $19.88M |
| % Insiders | 18.98% |
| % Institutions | 3.40% |
Data last updated: 4/7/2026